REsistance to Aspirin and Clopidogrel in acuTe Myocardial Infarction
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 154 participants.
Also called NCT01381185
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose diagnostic
- Phase
- Phase 4
- Enrolled
- 154 participants
- Sponsor
- Registry
-
NCT01381185
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Czechia
- Registry status
- Completed
Technical summary
Registry record NCT01381185. Non-randomized; no masking; primary purpose diagnostic. Start 2011-05 (registry gives no type); primary completion 2015-06 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- REsistance to Aspirin and Clopidogrel in acuTe Myocardial Infarction
- Acronym
- REACT-MI
- Condition
- Acute Myocardial Infarction
- Intervention (Drug)
- Aspirin 200mg qd, Clopidogrel 2x75mg qd
- Lead sponsor
- University Hospital Ostrava
Record details
- Record id
cardio:ct-nct01381185- Content hash
c5e3c5149c6daea0533176168b3a4db9c3c05d4681ba08b7597a4b275bfc6567